CAI Q3 2015 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+11.7% YoY

Gross Profit

$39M58.4% margin

Operating Income

$23M35.1% margin

Net Income

$13M19.6% margin

EPS (Diluted)

$0.62

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

-$27M

Stock-Based Comp.

$467,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.5B

Stockholders' Equity

$475M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$59M	+11.7%
Gross Profit	$39M	$39M	-1.7%
Operating Income	$23M	$26M	-10.9%
Net Income	$13M	$16M	-20.8%